Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for Documentation and Review of QC Results – V 2.0

Posted on By

API Manufacturing: SOP for Documentation and Review of QC Results – V 2.0

Standard Operating Procedure for Documentation and Review of QC Results in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/133/2025
Supersedes SOP/API/133/2022
Page No. Page 1 of 8
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To establish a clear and standardized procedure for the documentation, review, and approval of analytical test results generated during Quality Control (QC) analysis of raw materials, intermediates, and Active Pharmaceutical Ingredients (APIs).

2. Scope

This SOP is applicable to all QC personnel involved in the generation, recording, review,

and approval of test results within the API manufacturing facility. It includes manual entries, instrument printouts, electronic records, and analytical worksheets.

3. Responsibilities

  • QC Analyst: Accurately record test results, observations, and calculations in the approved format.
  • QC Reviewer: Verify correctness of data, calculations, and compliance with specifications.
  • QA Officer: Review completed records for completeness and adherence to data integrity principles.
See also  API Manufacturing: SOP for Use of Conductivity Meter in API Plant - V 2.0

4. Accountability

The QC Head is accountable for ensuring proper documentation practices and review controls are followed, in alignment with GMP and regulatory expectations.

5. Procedure

5.1 Documentation of Test Results

  1. Use blue or black permanent ink for manual entries. Corrections should be made by striking through the error with a single line, initialing, and writing the correct entry alongside.
  2. Document results in approved QC worksheets or logbooks immediately after test completion.
  3. Each result entry must be traceable to:
    • Sample ID / batch number
    • Test method / STP number
    • Instrument ID (if applicable)
    • Analyst initials and date
  4. Attach relevant instrument printouts (chromatograms, pH meter printouts, etc.) with sample ID and analyst signature.

5.2 Review of Results

  1. All results must be reviewed by a qualified reviewer who was not involved in performing the test.
  2. Ensure:
    • Calculations are correct
    • Values fall within the specification limits
    • Raw data matches reported values
    • Any OOS/OOT is clearly documented and investigated
  3. Sign and date all reviewed pages with comments, if applicable.
See also  API Manufacturing: SOP for FIFO and FEFO Implementation in Warehouse - V 2.0

5.3 Out-of-Specification (OOS) and Out-of-Trend (OOT) Handling

  1. OOS or OOT observations must be recorded in the data sheet and immediately notified to QA.
  2. Initiate the investigation as per the OOS/OOT SOP and attach a reference copy with the analytical report.
  3. Do not alter or overwrite original entries or results.

5.4 Approval and Archiving

  1. After review, QC Head or designee must approve the final analytical report with date and signature.
  2. Transfer completed and reviewed analytical records to the document control department for archival.
  3. Retain records for a minimum of 5 years post batch expiry or as per regulatory requirements.

5.5 Data Integrity Practices

  1. Follow ALCOA+ principles:
    • Attributable
    • Legible
    • Contemporaneous
    • Original
    • Accurate
    • Complete, Consistent, Enduring, and Available
  2. Avoid use of pencils, correction fluid, or unapproved abbreviations.
  3. Ensure all electronic data is backed up, secure, and access-controlled.

See also  API Manufacturing: SOP for LOD Testing During Drying Stage - V 2.0

6. Abbreviations

  • QC: Quality Control
  • QA: Quality Assurance
  • GMP: Good Manufacturing Practice
  • OOS: Out of Specification
  • OOT: Out of Trend
  • STP: Standard Test Procedure
  • ALCOA: Attributable, Legible, Contemporaneous, Original, Accurate

7. Documents

  1. QC Analytical Worksheet (Annexure-1)
  2. Instrument Printout Attachment Log
  3. OOS/OOT Investigation Form

8. References

  • ICH Q7 – GMP for APIs
  • 21 CFR Part 211 – US FDA
  • MHRA Data Integrity Guidance
  • WHO TRS 996 – Annex 5

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: QC Analytical Worksheet

Test Result Specification Instrument ID Analyst Date
Assay 99.2% 98.5–101.5% HPLC-03 Sunita Reddy 13/04/2025

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Release GMP Compliance QA Head
13/04/2025 2.0 Added ALCOA+ and archival controls Audit Observation QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Elixir Department: SOP for Preparation of Alcohol-Based Elixirs – V 2.0
Next Post: Biosimilars: SOP for Fed-Batch Cultivation Strategy in Bioreactor Operations – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version